MDM2 and prostate carcinoma: Further in vitro and in vivo studies showed that curcumin downregulates MDM2 expression in both p53-wild-type and p53-null prostate cancer cells by inhibiting the PI3K/mTOR/ETS2 pathway (Li et al., 2007[119]).